Is CROC or MRK a better dividend investment in 2026?

CROC currently yields 3.94% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: CROC offers higher current income.

What is the dividend yield difference between CROC and MRK?

CROC has a forward dividend yield of 3.94% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 0.69 percentage points.

Home › Compare › CROC vs MRK

CROC vs MRK: Dividend Comparison 2026

CROC yields 3.94% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MRK wins by $4.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CROC

● Live price

3.94%

Share price

$50.72

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.8K

Annual income

$507.90

Full CROC calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — CROC vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CROC	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CROC + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CROC pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CROC

Annual income on $10K today (after 15% tax)

$335.15/yr

After 10yr DRIP, annual income (after tax)

$431.72/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, MRK beats the other by $376.03/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CROC + MRK for your $10,000?

CROC: 50%MRK: 50%

100% MRK50/50100% CROC

Portfolio after 10yr

$28.3K

Annual income

$729.10/yr

Blended yield

2.58%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CROC

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CROC buys

MRK buys

No recent congressional trades found for CROC or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCROCMRK

Forward yield	3.94% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$25.8K	$30.7K ✓
Annual income after 10y	$507.90	$950.29 ✓
Total dividends collected	$4.5K	$6.1K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CROC vs MRK ($10,000, DRIP)

Year	CROC Portfolio	CROC Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$11,094	$394.30	$11,192	$351.54	$98.00 → MRK
2	$12,280	$408.83	$12,524	$392.70	$244.00 → MRK
3	$13,562	$422.91	$14,015	$438.65	$453.00 → MRK
4	$14,948	$436.52	$15,682	$489.96	$734.00 → MRK
5	$16,444	$449.65	$17,547	$547.23	$1.1K → MRK
6	$18,057	$462.29	$19,632	$611.16	$1.6K → MRK
7	$19,796	$474.44	$21,963	$682.53	$2.2K → MRK
8	$21,668	$486.08	$24,571	$762.18	$2.9K → MRK
9	$23,682	$497.24	$27,486	$851.08	$3.8K → MRK
10	$25,847	$507.90	$30,745	$950.29	$4.9K → MRK

CROC vs MRK: Complete Analysis 2026

CROC — Stock

The fund obtains short exposures to its benchmark through futures contracts on its underlying currency. It may also invest in forward contracts if the market for a specific futures contract experiences emergencies (e.g., natural disaster, terrorist attack or an act of God) or disruptions (e.g., a trading halt or a flash crash) or in situations where the Sponsor deems it impractical or inadvisable to buy or sell futures contracts.

Full CROC Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this CROC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CROC vs SCHD CROC vs JEPI CROC vs O CROC vs KO CROC vs MAIN CROC vs JNJ CROC vs ABBV CROC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.